Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010

The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis

“…Finally, the rate of opioid overdose deaths per 100,000 residents in 2013 was measured using data from the CDC's WONDER database (2015). Similar to the methodology described by Bachhuber et al (2014) …”

Commentary on Pardo (2017) and Moyo et al. (2017): Much still unknown about prescription drug monitoring programs

“…Even under ideal conditions, PDMPrelated reductions in OA deaths appear to be similar to those reported for laws and policies that increase access to the overdose reversal medication naloxone, for example, and lower than those associated with increased access to medical cannabis [2,17,18]. They are far lower than those associated with opioid agonist and partial agonist treatment [19].…”

Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in <em>Cannabis</em> Users

“…Patients cite improved symptom management, fewer adverse side effects, and milder withdrawal symptoms as reasons for switching from pharmaceuticals to medical Cannabis (Boehnke et al, 2016, Bradford and Bradford, 2016, Bradford et al, 2018, Haroutounian et al, 2016, Bachhuber et al, 2014, Lucas and Walsh, 2017, Lucas et al, 2013, Wen and Hockenberry, 2018. Once patients become aware that the side effects of medical Cannabis may include weight loss and reduced risk of obesity-associated medical conditions, this shift toward medical Cannabis is likely to accelerate.…”